In this podcast we speak to Claus Jensen, Enterprise Architect at Novozymes. Novozymes is a global biotechnology company headquartered in Denmark and focuses on the research, development, and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. We begin talking about how the COVID 19 pandemic has effected Novozymes and what the EA team we asked to do … then Claus goes into more detail about his vision for the “new normal” when for employees and consumers.